Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4313095)

Published in Sci Rep on February 02, 2015

Authors

Peng Chen1, Hai Yan1, Yaping Tian2, Yiping Xun1, Lili Shi1, Ran Bao1, Huai Zhang1, Guangyu Chen3, Chunhe Yang1, Shutao Sun4, Yajie Wang5, Li Liu6, Yabin Zhou1, Chunyan Zhang2, Xiaoxu Wang1, Yongqiang Wen1, Yongzhong Bian1, Hongwu Du1

Author Affiliations

1: School of Chemistry and Biotechnology Engineering, University of Science and Technology Beijing, Beijing 100083, China.
2: Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing 100853, China.
3: ImmunoHunt Corporation, 139 Fengtai Rd, Beijing 100071, China.
4: Core Facility, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
5: 1] Core Laboratory for Clinical Medical Research, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China [2] Department of Clinical Laboratory Diagnosis, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
6: Core Laboratory for Clinical Medical Research, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.

Articles citing this

HnRNP A1 is Involved in Deep Vein Thrombosis Patients with Behçet's Disease. EBioMedicine (2016) 0.75

Articles cited by this

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57

Behçet's disease. N Engl J Med (1999) 7.74

Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A (1983) 7.55

Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol (2003) 6.98

Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet (1988) 2.43

Heat shock proteins as regulators of the immune response. Lancet (2003) 2.42

An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem (1994) 2.22

Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02

Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood (2004) 2.01

Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci U S A (1992) 1.88

Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis (2005) 1.77

The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron (2011) 1.67

New insights into the pathogenesis of Behçet's disease. Autoimmun Rev (2011) 1.60

Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J Exp Med (1990) 1.57

Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet's disease. J Invest Dermatol (2011) 1.46

Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun (1991) 1.45

Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet (1991) 1.45

Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol (2010) 1.38

Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan. J Rheumatol (1989) 1.35

Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood (2006) 1.34

Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum (2003) 1.33

Annexin A2 is a soluble mediator of macrophage activation. J Leukoc Biol (2007) 1.14

New tools for classification and monitoring of autoimmune diseases. Nat Rev Rheumatol (2012) 1.13

Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol (2008) 1.13

Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome. Eur J Immunol (2002) 1.05

Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimmun Rev (2011) 1.02

Proteins at membrane surfaces-a review of approaches. Mol Biosyst (2007) 1.00

Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood (2007) 1.00

Annexin A2: its molecular regulation and cellular expression in cancer development. Dis Markers (2014) 0.99

Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol (1993) 0.99

The role of streptococcal hypersensitivity in the pathogenesis of Behçet's Disease. Eur J Dermatol (2008) 0.99

Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol (1990) 0.98

Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. J Immunol (1995) 0.98

Immunogenicity of autoantigens. BMC Genomics (2011) 0.97

ATF4 is directly recruited by TLR4 signaling and positively regulates TLR4-trigged cytokine production in human monocytes. Cell Mol Immunol (2012) 0.93

Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease. Arthritis Res Ther (2006) 0.91

Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis. Rheumatol Int (2010) 0.91

Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease. Exp Eye Res (2007) 0.88

Identification of kinectin as a novel Behçet's disease autoantigen. Arthritis Res Ther (2005) 0.88

Identification of prohibitin as an antigen in Behcet's disease. Biochem Biophys Res Commun (2014) 0.87

Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis. Invest Ophthalmol Vis Sci (2010) 0.87

Immunological screening and characterization of highly specific monoclonal antibodies against 20 kDa hGH. Bioanalysis (2012) 0.86

Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behçet's disease. Clin Exp Rheumatol (2008) 0.84

Anti-endothelial cell antibodies in Behçet's disease. Clin Exp Rheumatol (2004) 0.84

Generation and evaluation of antibodies against human MGF E-peptide by reverse phase protein microarray and reverse competitive ELISA. Bioanalysis (2013) 0.84

Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease. J Neuroimmunol (2013) 0.84

Anti-annexin V antibodies in neuro-Behçet patients: clinical significance and relation to disease activity. Int J Rheum Dis (2012) 0.84

Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies. Mol Immunol (2009) 0.83

Modulation of the major histocompatibility complex by neural stem cell-derived neurotrophic factors used for regenerative therapy in a rat model of stroke. J Transl Med (2010) 0.81

The correlation of MHC haplotype and development of Behçet's disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci (2001) 0.81

Development of miniaturized competitive immunoassays on a protein chip as a screening tool for drugs. Clin Chem (2004) 0.80

Preparation of steroid antibodies and parallel detection of multianabolic steroid abuse with conjugated hapten microarray. Anal Chem (2004) 0.78

Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis. Rheumatol Int (2012) 0.77

Efficient enrichment and identification of phosphopeptides by cerium oxide using on-plate matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Rapid Commun Mass Spectrom (2011) 0.77

Multiple correlations of mRNA expression and protein abundance in human cytokine profile. Mol Biol Rep (2014) 0.76